Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans
Kyung Hun Kim,1,2 Seo Hyun Lim,2 Cho Rok Shim,2 Junsung Park,2 Woo Heon Song,2 Min Chang Kwon,2 Jong Hyuk Lee,3 Jun Sang Park,2 Han-Gon Choi1 1College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea; 2GL PharmTech Corp, Seongnam, Repub...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-01-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/development-of-a-novel-controlled-release-tablet-of-pregabalin-formula-peer-reviewed-article-DDDT |
id |
doaj-f358ec0a7167421c88b4e97efd5ecab5 |
---|---|
record_format |
Article |
spelling |
doaj-f358ec0a7167421c88b4e97efd5ecab52020-11-25T01:44:37ZengDove Medical PressDrug Design, Development and Therapy1177-88812020-01-01Volume 1444545651460Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and HumansKim KHLim SHShim CRPark JSong WHKwon MCLee JHPark JSChoi HGKyung Hun Kim,1,2 Seo Hyun Lim,2 Cho Rok Shim,2 Junsung Park,2 Woo Heon Song,2 Min Chang Kwon,2 Jong Hyuk Lee,3 Jun Sang Park,2 Han-Gon Choi1 1College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea; 2GL PharmTech Corp, Seongnam, Republic of Korea; 3Department of Pharmaceutical Engineering, College of Life and Health Sciences, Hoseo University, Asan, Republic of KoreaCorrespondence: Jun Sang ParkGL PharmTech Corp, #714, Jungang Induspia V, 137 #714, Jungang Induspia V, 137, Seongnam-Si, Gyeonggi-Do 13202, South KoreaTel +82-31-739-5220Fax +82-31-739-5224Email jspark@glpt.co.krHan-Gon ChoiCollege of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of KoreaEmail hangon@hanyang.ac.krBackground: Novel three-layered (TL) tablet systems were compared with both monolithic matrix (MM) formulations and a commercial immediate-release (IR) capsule to develop once-a-day (OAD) pregabalin tablets.Methods: The physical properties of the TL tablets, including dissolution and swelling rates, were compared with those of the MM tablets and the pharmacokinetic parameters of the TL tablet were compared with those of an IR capsule in beagles and humans.Results: Our results indicated that the same amount of a hydrophilic polymer in the formulations had similar dissolution profiles at 12 h, regardless of the tablet geometry. However, the degree of tablet swelling differed, with larger amounts of polymer in the tablets showing a greater degree of swelling. In addition, TL tablets swelled more rapidly compared with MM tablets. For the pharmacokinetic study of the TL tablet, the beagles demonstrated absorption results similar to those of an IR capsule, whereas the humans demonstrated low total absorption compared with an IR capsule. The time of the peak plasma concentration at 6 h in the fed state of humans coincided with the results of the study on beagles.Conclusion: The novel TL tablet system of pregabalin may prove to be helpful in developing improved formulations with better continuous drug absorption for OAD administration.Keywords: controlled-release, three-layered tablet, polyethylene oxide, high swellable, once-a-dayhttps://www.dovepress.com/development-of-a-novel-controlled-release-tablet-of-pregabalin-formula-peer-reviewed-article-DDDTcontrolled-releasethree-layered tabletpolyethylene oxidehigh swellableonce-a-day |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kim KH Lim SH Shim CR Park J Song WH Kwon MC Lee JH Park JS Choi HG |
spellingShingle |
Kim KH Lim SH Shim CR Park J Song WH Kwon MC Lee JH Park JS Choi HG Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans Drug Design, Development and Therapy controlled-release three-layered tablet polyethylene oxide high swellable once-a-day |
author_facet |
Kim KH Lim SH Shim CR Park J Song WH Kwon MC Lee JH Park JS Choi HG |
author_sort |
Kim KH |
title |
Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans |
title_short |
Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans |
title_full |
Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans |
title_fullStr |
Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans |
title_full_unstemmed |
Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans |
title_sort |
development of a novel controlled-release tablet of pregabalin: formulation variation and pharmacokinetics in dogs and humans |
publisher |
Dove Medical Press |
series |
Drug Design, Development and Therapy |
issn |
1177-8881 |
publishDate |
2020-01-01 |
description |
Kyung Hun Kim,1,2 Seo Hyun Lim,2 Cho Rok Shim,2 Junsung Park,2 Woo Heon Song,2 Min Chang Kwon,2 Jong Hyuk Lee,3 Jun Sang Park,2 Han-Gon Choi1 1College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea; 2GL PharmTech Corp, Seongnam, Republic of Korea; 3Department of Pharmaceutical Engineering, College of Life and Health Sciences, Hoseo University, Asan, Republic of KoreaCorrespondence: Jun Sang ParkGL PharmTech Corp, #714, Jungang Induspia V, 137 #714, Jungang Induspia V, 137, Seongnam-Si, Gyeonggi-Do 13202, South KoreaTel +82-31-739-5220Fax +82-31-739-5224Email jspark@glpt.co.krHan-Gon ChoiCollege of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of KoreaEmail hangon@hanyang.ac.krBackground: Novel three-layered (TL) tablet systems were compared with both monolithic matrix (MM) formulations and a commercial immediate-release (IR) capsule to develop once-a-day (OAD) pregabalin tablets.Methods: The physical properties of the TL tablets, including dissolution and swelling rates, were compared with those of the MM tablets and the pharmacokinetic parameters of the TL tablet were compared with those of an IR capsule in beagles and humans.Results: Our results indicated that the same amount of a hydrophilic polymer in the formulations had similar dissolution profiles at 12 h, regardless of the tablet geometry. However, the degree of tablet swelling differed, with larger amounts of polymer in the tablets showing a greater degree of swelling. In addition, TL tablets swelled more rapidly compared with MM tablets. For the pharmacokinetic study of the TL tablet, the beagles demonstrated absorption results similar to those of an IR capsule, whereas the humans demonstrated low total absorption compared with an IR capsule. The time of the peak plasma concentration at 6 h in the fed state of humans coincided with the results of the study on beagles.Conclusion: The novel TL tablet system of pregabalin may prove to be helpful in developing improved formulations with better continuous drug absorption for OAD administration.Keywords: controlled-release, three-layered tablet, polyethylene oxide, high swellable, once-a-day |
topic |
controlled-release three-layered tablet polyethylene oxide high swellable once-a-day |
url |
https://www.dovepress.com/development-of-a-novel-controlled-release-tablet-of-pregabalin-formula-peer-reviewed-article-DDDT |
work_keys_str_mv |
AT kimkh developmentofanovelcontrolledreleasetabletofpregabalinformulationvariationandpharmacokineticsindogsandhumans AT limsh developmentofanovelcontrolledreleasetabletofpregabalinformulationvariationandpharmacokineticsindogsandhumans AT shimcr developmentofanovelcontrolledreleasetabletofpregabalinformulationvariationandpharmacokineticsindogsandhumans AT parkj developmentofanovelcontrolledreleasetabletofpregabalinformulationvariationandpharmacokineticsindogsandhumans AT songwh developmentofanovelcontrolledreleasetabletofpregabalinformulationvariationandpharmacokineticsindogsandhumans AT kwonmc developmentofanovelcontrolledreleasetabletofpregabalinformulationvariationandpharmacokineticsindogsandhumans AT leejh developmentofanovelcontrolledreleasetabletofpregabalinformulationvariationandpharmacokineticsindogsandhumans AT parkjs developmentofanovelcontrolledreleasetabletofpregabalinformulationvariationandpharmacokineticsindogsandhumans AT choihg developmentofanovelcontrolledreleasetabletofpregabalinformulationvariationandpharmacokineticsindogsandhumans |
_version_ |
1725027550609014784 |